Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health Ruchika Sharma26 April 2025 12:36 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the Committee...
USFDA classifies Biocon Biologics Biocon Park Site in Bengaluru as VAI Ruchika Sharma11 Nov 2024 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' facilities at Biocon Park,...
Biocon Biologics refinances USD 1.1 billion long term debt through USD Bonds new syndicated facility Ruchika Sharma5 Oct 2024 11:30 AM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced the successful pricing of Biocon Biologics' debut USD 800 million...
Biocon arm completes integration of Viatris biosimilars business in 120 countries Ruchika Sharma19 Dec 2023 11:43 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful completion of the transition of the acquired...
Biocon Biologics bags 'ABEA : Bioprocessing Excellence in South Asia' Award Ruchika Sharma28 March 2023 4:15 PM ISTBiocon Biologics was recognized as the winner as it garnered the maximum number of votes from among 70,000 biopharma professionals who participated in...
Biocon Biologics names Shreehas Tambe as new MD, CEO Ruchika Sharma5 Dec 2022 4:15 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been...
Viatris sells global biosimilars business to Biocon Biologics for USD 3 billion Ruchika Sharma30 Nov 2022 11:23 AM ISTThe acquisition provides Biocon Biologics with direct commercial capabilities and supporting infrastructure in the advanced markets and several...
Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan Ruchika Sharma17 Oct 2022 2:30 PM ISTDenosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
CCI approves Serum Institute Life Sciences-Biocon Biologics deal Medical Dialogues Bureau19 May 2022 3:12 PM ISTNew Delhi: The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies...
Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids Ruchika Sharma15 Nov 2021 4:12 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 3:28 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance Ruchika Sharma17 Sept 2021 12:48 PM ISTBengaluru: Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum...
